CFM
MDT icon

Catalyst Funds Management’s Medtronic MDT Stock Holding History

Catalyst Funds Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,000
Closed -$381K – 479
2025
Q3 		$381K Buy
+4,000
New +$368K 0.06% 287
2025
Q1 		– Sell
-32,400
Closed -$2.59M – 536
2024
Q4 		$2.59M Hold
32,400
– – 0.63% 35
2024
Q3 		$2.92M Buy
32,400
+28,800
+800% +$2.42M 0.64% 18
2024
Q2 		$283K Sell
3,600
-500
-12% -$41K 0.08% 169
2024
Q1 		$357K Buy
+4,100
New +$350K 0.1% 168

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Catalyst Funds Management's MDT Position: Q4 2025 in Review

Catalyst Funds Management sold out of Medtronic (MDT) in Q4 2025, closing a stake of 4,000 shares — an estimated $381K sold.

Catalyst Funds Management first reported a position in MDT in Q1 2024 and held it in 5 quarters. The position peaked at $2.92M in Q3 2024. 2,315 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Catalyst Funds Management reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • Catalyst Funds Management sold 4,000 Medtronic shares in Q4 2025, an estimated $381K.
  • Catalyst Funds Management first reported a position in Medtronic in Q1 2024 and held it in 5 quarters.
  • Catalyst Funds Management's Medtronic position peaked at $2.92M in Q3 2024.
  • 2,315 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Catalyst Funds Management's 13F filing for Q4 2025, filed 9 Feb 2026.